Darusentan
Darusentan
Darusentan (pronounced dah-roo-sen-tan) is a type of pharmaceutical drug used in the treatment of pulmonary arterial hypertension (PAH). It is classified as an endothelin receptor antagonist (ERA), which works by blocking the action of endothelin, a substance in the body that constricts blood vessels and raises blood pressure.
Etymology
The name "Darusentan" is derived from the class of drugs it belongs to, the endothelin receptor antagonists. The prefix "Dar-" is arbitrary, while "-sentan" is a common suffix for drugs in this class.
Usage
Darusentan is used to treat pulmonary arterial hypertension, a condition characterized by high blood pressure in the arteries that supply the lungs. By blocking the action of endothelin, Darusentan helps to relax and widen these arteries, reducing blood pressure and improving symptoms.
Related Terms
- Endothelin: A peptide that constricts blood vessels and raises blood pressure. It is the target of Darusentan's action.
- Endothelin receptor antagonist: A class of drugs that block the action of endothelin. Darusentan is a member of this class.
- Pulmonary arterial hypertension: A condition characterized by high blood pressure in the arteries that supply the lungs. It is the condition that Darusentan is used to treat.
See Also
External links
- Medical encyclopedia article on Darusentan
- Wikipedia's article - Darusentan
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski